Source: Endocrine-Related Cancer. Unidade: FM
Subjects: ENDOCRINOPATIAS (PATOLOGIA), ENDOCRINOPATIAS (IMUNOLOGIA), NEOPLASIAS (DIAGNÓSTICO), IMUNOHISTOQUÍMICA
ABNT
SÁ, Sandra Valéria de et al. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas. Endocrine-Related Cancer, v. 13, p. 69-78, 2006Tradução . . Disponível em: https://doi.org/10.1677/erc.1.00962. Acesso em: 21 maio 2024.APA
Sá, S. V. de, Giannella, M. L. C. C., Machado, M. C., Souza, J. J. S. de, Pereira, M. A. A., Patzina, R. A., et al. (2006). Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas. Endocrine-Related Cancer, 13, 69-78. doi:10.1677/erc.1.00962NLM
Sá SV de, Giannella MLCC, Machado MC, Souza JJS de, Pereira MAA, Patzina RA, Siqueira SAC, Machado MCC, Giannella Neto D. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas [Internet]. Endocrine-Related Cancer. 2006 ; 13 69-78.[citado 2024 maio 21 ] Available from: https://doi.org/10.1677/erc.1.00962Vancouver
Sá SV de, Giannella MLCC, Machado MC, Souza JJS de, Pereira MAA, Patzina RA, Siqueira SAC, Machado MCC, Giannella Neto D. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas [Internet]. Endocrine-Related Cancer. 2006 ; 13 69-78.[citado 2024 maio 21 ] Available from: https://doi.org/10.1677/erc.1.00962